Back to BLCOView full pipeline
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
Upcoming Catalysts
What are catalysts?Competitive Landscape
0 competitors in Dementia Alzheimer Type
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Rifaximin SSDPhase 3
Overt Hepatic Encephalopathy
N-methylnaltrexone bromide (MOA-728)Phase 3
Constipation
Methylnaltrexone (MOA-728)Phase 3
Post Operative Bowel Dysfunction
Granulated mesalaminePhase 3
Ulcerative Colitis
Brimonidine tartrate ophthalmicPhase 3
Seasonal Allergic Conjunctivitis
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
